Cognition Therapeutics, Inc. (CGTX) NASDAQ
1.35
+0.1(+8.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.35
+0.1(+8.00%)
Currency In USD
| Market Cap | 98.24M |
| Enterprise Value | 62.06M |
| P/E Ratio | -6.15 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.03 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.91 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.54 |
| Return On Equity | -0.73 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -23.25M |
| Net Income | -23.49M |
| Diluted EPS | -0.32 |
| Total Cash | 31.13M |
| Total Cash/Share | 0.35 |
| Total Debt | 465,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 5.92 |
| Book Value Per Share | 0.34 |
| 52-Week Change | 325.87 |
| 52-Week High | 3.83 |
| 52-Week Low | 0.25 |
| Moving Average 50 Days | 1.11 |
| Moving Average 200 Days | 1.44 |
| Average Volume | 1.18M |
| Shares Outstanding | 73.58M |
| % Held by Institutions | 29.43 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |